- Efficacy and safety of rivaroxaban versus warfarin in the ...🔍
- Efficacy and safety of rivaroxaban vs. warfarin in patients with non ...🔍
- Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus ...🔍
- Safety and Effectiveness of Rivaroxaban Versus Warfarin Across ...🔍
- Evaluation of the efficacy and safety of rivaroxaban compared to ...🔍
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation🔍
- Efficacy and Safety of Rivaroxaban Compared With Warfarin Among ...🔍
- Efficacy and Safety of Rivaroxaban versus Warfarin for the ...🔍
Efficacy and safety of rivaroxaban versus warfarin in the ...
Efficacy and safety of rivaroxaban versus warfarin in the ... - Frontiers
Rivaroxaban exhibited comparable efficacy for the anticoagulant treatment of unusual site DVT, associated with a lower risk of bleeding complications and major ...
Efficacy and safety of rivaroxaban vs. warfarin in patients with non ...
In ROCKET AF, a history of cancer was associated with a higher risk of bleeding and non-cardiovascular death, but not ischaemic events.
Efficacy and safety of rivaroxaban versus warfarin in the ... - PubMed
Compared with warfarin, rivaroxaban exhibited comparable efficacy for the anticoagulant treatment of unusual site DVT, associated with a ...
Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus ...
Patients treated with 0 to 4 medications had lower rates of major bleeding with rivaroxaban (adjusted hazard ratio, 0.71; 95% confidence ...
Safety and Effectiveness of Rivaroxaban Versus Warfarin Across ...
Rivaroxaban compared with warfarin was associated with lower or similar risk of all-cause death, ischemic stroke and transient ischemic attack and similar risk ...
Evaluation of the efficacy and safety of rivaroxaban compared to ...
The trial demonstrated that rivaroxaban is as effective as warfarin in terms of thrombus resolution rate, reduction in thrombus size, bleeding risk, and ...
Efficacy and safety of rivaroxaban vs. warfarin in patients with non ...
Although based on a small number of events, trends of haemorrhagic stroke, intracranial haemorrhage, critical organ bleeding, and fatal bleeding were lower ...
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
There was no significant between-group difference in the risk of major bleeding, although intracranial and fatal bleeding occurred less ...
Efficacy and Safety of Rivaroxaban Compared With Warfarin Among ...
The relative effects of rivaroxaban and warfarin were consistent among elderly and younger patients for both treatment efficacy and safety. Anticoagulation with ...
Efficacy and Safety of Rivaroxaban versus Warfarin for the ...
Table 5 shows that the primary efficacy outcome and principal safety outcome were similar between groups except for the rate of all-cause mortality in PE ...
Effectiveness and safety of rivaroxaban versus warfarin in obese ...
Among obese NVAF patients, prescription of rivaroxaban was associated with a reduced risk of SSE and major bleeding compared to warfarin, which remained ...
Effectiveness and safety of rivaroxaban versus warfarin among ...
In this study, we evaluated the effectiveness and safety of rivaroxaban compared with warfarin in NVAF patients with both obesity and diabetes.
Effectiveness and Safety of Rivaroxaban versus Warfarin Among ...
Rivaroxaban was associated with lower risks of stroke and systemic embolism and similar risk of major bleeding versus warfarin across polypharmacy categories.
Effectiveness and safety of rivaroxaban vs. warfarin in patients 80+ ...
Non-valuvular atrial fibrillation (NVAF) is common among the elderly; with >50% NVAF patients being ≥80 years of age.
A Comparative Study of the Clinical Benefits of Rivaroxaban and ...
Rivaroxaban is superior to warfarin in reducing fatal bleeding and bleeding in critical organs. Clinical Trial Registration: Chinese Clinical Trials Registry, ...
Rivaroxaban vs warfarin in high-risk patients with antiphospholipid ...
Rivaroxaban is an effective and safe alternative to warfarin in patients with atrial fibrillation and venous thromboembolism.
Real-world effectiveness and safety of rivaroxaban versus warfarin ...
These results suggest that rivaroxaban is an effective and safe treatment option among NVAF patients with obesity in a commercially-insured US population.
Comparative Effectiveness and Safety of Rivaroxaban and Warfarin ...
Current evidence indicates that rivaroxaban may be a safe and effective alternative to warfarin among patients with nonvalvular atrial ...
Evaluating the efficacy and safety of rivaroxaban as a warfarin ...
Most studies conducted to compare the safety and efficacy of rivaroxaban and warfarin have been conducted on PE and DVT patients. Clinical trials evaluating ...
Efficacy and safety of rivaroxaban vs warfarin in high-risk patients ...
This is a multicentre, randomized, open-label, study that will evaluate if Rivaroxaban is non-inferior to warfarin for the prevention of thromboembolic ...